Currently, the recognition of signs of lower motor neuron degeneration in SCA2 acquires additional clinical and pathogenetic relevance given the known relationship between the intermediate alleles of ATXN2 gene and increased risk of amyotrophic lateral sclerosis (ALS) (34). The gene discussed is ATXN2; the disease is spinocerebellar ataxia type 2.